Cancer mortality cut by a third in young people
Author: Louise Prime
Cancer mortality in young people in England has fallen by almost a third since 2001, an analysis of official figures revealed this morning. However, they also showed that geography and deprivation still have a significant impact on cancer incidence and five-year survival rates across the country.
The Teenage Cancer Trust collaborated with the National Cancer Registration and Analysis Service to take an in-depth look at Public Health England’s statistics on incidence, mortality and survival of 13-24 year olds diagnosed with cancer in England between 2001 and 2015. Their joint report* showed that:
- Mortality rates of all cancers combined in 13-24 year olds have decreased from 42.9 per million in 2001 to 32.3 per million in 2015.
- The largest reduction in mortality by diagnostic group in England between 2001 and 2015 has been in leukaemias. There were also reductions seen in mortality from central nervous system tumours, bone cancer and in lymphoma.
- Five-year survival rates for cancer in 13-24 year olds have risen from 83% in females and 80% in males in 2001-05 to 87% in females and 84 % males in 2007-11.
- For deprivation scores based on postcode, young people in quintile 2 were at significantly greater risk of incident cancer diagnosis than those in quintile 4 (310.1 per million person-years vs 276.8 per million). Furthermore, those diagnosed between 2007 and 2011 in the least deprived quintile had significantly higher five-year survival (88%) than those in quintile 2 and in the two most deprived quintiles (84%).
- The incidence of cancer in 13-24 year olds in England has increased from a crude rate of 233.1 per million in 2001, to 299.7 per million in 2015.
The Teenage Cancer Trust welcomed the report’s findings that, for the first time, cancer survival rates are improving in young people and pointed out that “this hugely positive shift” has occurred since the National Institute for Health and Care Excellence (NICE) decided in 2005 to recognise and treat teenagers and young adults as a unique patient group – and embedded within the NHS the model of care that the charity had pioneered and invested in. It added: “This report makes a strong case for the importance of such services and for sustained funding of teenage and young adult specialist care into the future”.
The charity’s chief executive Kate Collins commented this morning: “Despite the encouraging progress being made on survival rates, now is not a time for complacency but even more action.
“Last week, NHS England in their long-term plan explicitly recognised the need to prioritise young people with cancer including a move to record the DNA of every child with cancer to develop personalised treatment and an aim of 50% of young people with cancer accessing clinical trials by 2025. Their implementation plan will be key in meeting these targets, especially further investing in an expert workforce and creating effective and integrated staff networks.”